Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - noradrenaline acid tartrate monohydrate 0.12 mg/ml equivalent to noradrenaline 0.06mg/ml;  ;   - solution for infusion - 3 mg/50ml - active: noradrenaline acid tartrate monohydrate 0.12 mg/ml equivalent to noradrenaline 0.06mg/ml     excipient: hydrochloric acid sodium chloride water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions). as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - noradrenaline acid tartrate monohydrate 0.2 mg/ml equivalent to noradrenaline 0.1mg/ml;  ;   - solution for infusion - 5 mg/50ml - active: noradrenaline acid tartrate monohydrate 0.2 mg/ml equivalent to noradrenaline 0.1mg/ml     excipient: hydrochloric acid sodium chloride water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions). as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - noradrenaline acid tartrate monohydrate 0.24 mg/ml equivalent to noradrenaline 0.12mg/ml;  ;   - solution for infusion - 6 mg/50ml - active: noradrenaline acid tartrate monohydrate 0.24 mg/ml equivalent to noradrenaline 0.12mg/ml     excipient: hydrochloric acid sodium chloride water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions). as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - nitrofurantoin, quantity: 100 mg - capsule, hard - excipient ingredients: titanium dioxide; lactose monohydrate; iron oxide yellow; maize starch; purified talc; purified water; gelatin; sodium lauryl sulfate - treatment of urinary tract infections such as cystitis and pyelitis when due to susceptible pathogens. nitrofurantoin does not reach effective levels in plasma and consequently is not indicated for cortical or perinephric abscesses and in cases of prostatitis.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - nitrofurantoin, quantity: 50 mg - capsule, hard - excipient ingredients: titanium dioxide; maize starch; purified talc; iron oxide yellow; lactose monohydrate; purified water; gelatin; sodium lauryl sulfate - treatment of urinary tract infections such as cystitis and pyelitis when due to susceptible pathogens. nitrofurantoin does not reach effective levels in plasma and consequently is not indicated for cortical or perinephric abscesses and in cases of prostatitis.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - omeprazole, quantity: 2 mg/ml - suspension, powder for - excipient ingredients: sodium bicarbonate; potassium bicarbonate; sodium alginate; mannitol; sucralose; xanthan gum; sodium benzoate; sodium methyl hydroxybenzoate; maltitol; titanium dioxide; flavour - omeprazole advz is indicated for:- adults -treatment of duodenal ulcers - prevention of relapse of duodenal ulcers - treatment of gastric ulcers - prevention of relapse of gastric ulcers - in combination with appropriate antibiotics, helicobacter pylori (h. pylori) eradication in peptic ulcer disease - treatment of nsaid-associated gastric and duodenal ulcers - prevention of nsaid-associated gastric and duodenal ulcers in patients at risk - treatment of reflux oesophagitis - long-term management of patients with healed reflux oesophagitis - treatment of symptomatic gastro-oesophageal reflux disease (gord) paediatric use children over 1 month of age - treatment of reflux oesophagitis - symptomatic treatment of heartburn and acid regurgitation in gord children over 4 years of age and adolescents in combination with antibiotics in treatment of duodenal ulcer caused by h. pylori

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - omeprazole, quantity: 4 mg/ml - suspension, powder for - excipient ingredients: sodium bicarbonate; potassium bicarbonate; sodium alginate; mannitol; sucralose; xanthan gum; sodium benzoate; sodium methyl hydroxybenzoate; maltitol; titanium dioxide; flavour - omeprazole advz is indicated for:- adults -treatment of duodenal ulcers - prevention of relapse of duodenal ulcers - treatment of gastric ulcers - prevention of relapse of gastric ulcers - in combination with appropriate antibiotics, helicobacter pylori (h. pylori) eradication in peptic ulcer disease - treatment of nsaid-associated gastric and duodenal ulcers - prevention of nsaid-associated gastric and duodenal ulcers in patients at risk - treatment of reflux oesophagitis - long-term management of patients with healed reflux oesophagitis - treatment of symptomatic gastro-oesophageal reflux disease (gord) paediatric use children over 1 month of age - treatment of reflux oesophagitis - symptomatic treatment of heartburn and acid regurgitation in gord children over 4 years of age and adolescents in combination with antibiotics in treatment of duodenal ulcer caused by h. pylori

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - amiodarone hydrochloride 50 mg/ml - concentrate for injection - 50 mg/ml - active: amiodarone hydrochloride 50 mg/ml excipient: benzyl alcohol hydrochloric acid polysorbate 80 sodium hydroxide water for injection - treatment should be initiated only under hospital or specialist supervision. indicated for treatment of · tachyarrhythmias associated with wolff-parkinson-white syndrome. · all types of tachyarrhythmias including · supraventricular, nodal and ventricular tachycardias, atrial flutter and fibrillation; · ventricular fibrillation; · when other agents cannot be used. the injection is to be used when a rapid response is required.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - cefalexin monohydrate 262.9mg equivalent to 250 mg cefalexin anhydrous. - capsule - 250 mg - active: cefalexin monohydrate 262.9mg equivalent to 250 mg cefalexin anhydrous. excipient: hard gelatin capsules size "2" tekprint sw-9008 black ink magnesium stearate microcrystalline cellulose

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - cefalexin monohydrate 525.8mg equivalent to 500 mg cefalexin anhydrous. - capsule - 500 mg - active: cefalexin monohydrate 525.8mg equivalent to 500 mg cefalexin anhydrous. excipient: hard gelatin capsules size "0" tekprint sw-9008 black ink magnesium stearate microcrystalline cellulose